Invention Grant
- Patent Title: Compounds for the prevention and treatment of glucose intolerance related conditions and obesity
-
Application No.: US16652947Application Date: 2018-10-04
-
Publication No.: US11491117B2Publication Date: 2022-11-08
- Inventor: Dominique Gauguier , Fumihiko Matsuda , François Brial
- Applicant: SORBONNE UNIVERSITÉ , INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) , ASSISTANCE PUBLIQUE—HÔPITAUX DE PARIS , KYOTO UNIVERSITY
- Applicant Address: FR Paris; FR Paris; FR Paris; JP Kyoto
- Assignee: SORBONNE UNIVERSITÉ,INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM),ASSISTANCE PUBLIQUE—HÔPITAUX DE PARIS,KYOTO UNIVERSITY
- Current Assignee: SORBONNE UNIVERSITÉ,INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM),ASSISTANCE PUBLIQUE—HÔPITAUX DE PARIS,KYOTO UNIVERSITY
- Current Assignee Address: FR Paris; FR Paris; FR Paris; JP Kyoto
- Agency: Christensen O'Connor Johnson & Kindness
- Priority: EP17306326 20171004
- International Application: PCT/EP2018/076958 WO 20181004
- International Announcement: WO2019/068788 WO 20190411
- Main IPC: A61K31/05
- IPC: A61K31/05 ; A61P3/10 ; A61K9/00
Abstract:
The disclosure pertains to a compound of formula (I), one of its pharmaceutically acceptable salts, or a composition comprising thereof, for use in the prevention or treatment of glucose intolerance related conditions, insulin deficit related conditions, nonalcoholic fatty liver disease and/or obesity.
Public/Granted literature
- US20200253889A1 COMPOUNDS FOR THE PREVENTION AND TREATMENT OF GLUCOSE INTOLERANCE RELATED CONDITIONS AND OBESITY. Public/Granted day:2020-08-13
Information query
